08045804946
Send Inquiry
pegasta 6mg inj
2200.0 INR/Strip
Product Details:
- Pacakaging (Quantity Per Box) 1 syringe per box
- Brand Name Pegasta
- Life Span 24 months from the date of manufacture
- Origin of Medicine India
- Indication Prevention of neutropenia in cancer patients receiving myelosuppressive chemotherapy
- Packaging Type Prefilled Syringe
- Salt Composition Pegfilgrastim
- Click to View more
X
pegasta 6mg inj Price And Quantity
- 2200.0 INR/Strip
- 1 Number
- Haematopoietic growth factors
- Subcutaneous injection
- Schedule H (Prescription Drug)
- Hypersensitivity to Pegfilgrastim or any component
- Prescription required
- Clear, colorless liquid
- Bone pain, muscle pain, headache, injection site reactions
pegasta 6mg inj Product Specifications
- Pegasta
- Patients undergoing chemotherapy-induced neutropenia
- Adults
- 1 syringe per box
- Stimulates production of neutrophils
- Injection
- 1 prefilled syringe of 6mg/0.6ml
- As prescribed by the physician
- 24 months from the date of manufacture
- India
- Prevention of neutropenia in cancer patients receiving myelosuppressive chemotherapy
- Biological / Biosimilar
- Parenteral (Injection)
- Prefilled Syringe
- Administer subcutaneously as per medical advice
- Pegfilgrastim 6mg
- Pegfilgrastim
- Store between 2C - 8C. Do not freeze. Protect from light.
- Haematopoietic growth factors
- Subcutaneous injection
- Schedule H (Prescription Drug)
- Hypersensitivity to Pegfilgrastim or any component
- Prescription required
- Clear, colorless liquid
- Bone pain, muscle pain, headache, injection site reactions
pegasta 6mg inj Trade Information
- Cash Advance (CA), Cash on Delivery (COD), Cash in Advance (CID)
- 1000 Number Per Week
- 2 Days
- No
- Asia, Australia, Central America, North America, South America, Eastern Europe, Western Europe, Middle East, Africa
- All India
Product Description
- Active Ingredient: Pegfilgrastim 6mg.
- Mechanism of Action: Pegfilgrastim works by stimulating the bone marrow to produce more white blood cells, specifically neutrophils, which are crucial for fighting infections.
- Primary Use: To decrease the incidence and duration of neutropenia (abnormally low white blood cell count) and the associated risk of fever and infection in patients receiving myelosuppressive anti-cancer drugs.
- Administration: It is typically given as a single subcutaneous injection (under the skin) once per chemotherapy cycle, usually at least 24 hours after the completion of chemotherapy. It should be administered by a qualified healthcare professional.
- Form: The medication often comes as a pre-filled syringe (PFS) or a penfill injection device.
- Storage: It needs to be stored in a refrigerator (2C to 8C) and protected from light; it should not be frozen. For a more comfortable injection, the syringe can be left at room temperature for 30 minutes before use.
How Does Pegasta 6mg Injection Work?
Pegasta 6mg belongs to the class of haematopoietic growth factors and contains pegfilgrastim as its active ingredient. It acts by stimulating the bone marrow to increase the production of neutrophils, a type of white blood cell crucial for fighting infections. This is especially important for patients receiving chemotherapy, as such treatments can significantly lower blood cell counts.
When Is Pegasta 6mg Injection Recommended?
This injection is typically prescribed for adults undergoing myelosuppressive chemotherapy who are at risk of developing neutropenia-a condition marked by an abnormally low count of neutrophils. Its main usage is for the prevention, rather than treatment, of chemotherapy-induced neutropenia.
Proper Administration and Storage of Pegasta
Pegasta 6mg Injection should be administered subcutaneously, precisely as advised by your healthcare provider. This medication is supplied in a prefilled syringe, intended for single use. It is crucial to store Pegasta between 2C and 8C, protect it from light, and never freeze it to maintain its effectiveness.
FAQ's of pegasta 6mg inj:
Q: What is the primary benefit of using Pegasta 6mg Injection during chemotherapy?
A: Pegasta 6mg Injection reduces the risk of neutropenia in patients undergoing chemotherapy, thereby lowering the likelihood of infection and enabling the body to better tolerate cancer treatment.Q: How should Pegasta 6mg Injection be administered?
A: It should be administered as a subcutaneous injection, typically in the upper arm, thigh, or abdomen, under the supervision or guidance of a healthcare professional.Q: When should Pegasta 6mg Injection be given in relation to chemotherapy?
A: Your physician will determine the timing, but Pegasta is usually administered at least 24 hours after chemotherapy has been completed to optimize its effectiveness in boosting neutrophil counts.Q: What precautions should be observed while storing Pegasta 6mg Injection?
A: Store the syringe in a refrigerator at 2C to 8C, protect it from direct light, and ensure it is not frozen. Keep out of reach of children.Q: Are there any contraindications or conditions where Pegasta should not be used?
A: Pegasta should not be used by individuals with hypersensitivity to Pegfilgrastim or any of its components. Always inform your doctor of any allergies or previous reactions.Q: What are the possible side effects of Pegasta 6mg Injection?
A: Common side effects may include bone pain, muscle pain, headaches, and mild reactions at the injection site. If you experience severe or unexpected symptoms, contact your physician promptly.Q: Is Pegasta 6mg Injection suitable for self-administration at home?
A: Administration should only be performed if your doctor has instructed and shown you the correct technique. Otherwise, it should be given by qualified healthcare professionals.Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Other Products in 'Anti Cancer Medicines' category
Contact Us
- Office No. - 5, Ground Floor, D R Shopping Center, Dattapada Road, Near Hdfc Bank, Borivali East,Mumbai - 400066, Maharashtra, India
- Phone : 08045804946
- Mr Ranjeet Singh (CEO & Founder)
- Mobile : 08045804946
- medisus.pharma007@gmail.com
Send Inquiry
Send SMS
Call Me FreeMEDISUS PHARMA
All Rights Reserved.(Terms of Use)
Developed and Managed by Infocom Network Private Limited.
Developed and Managed by Infocom Network Private Limited.
